Averx Drugs Private Limited - Company Profile

It is a pharma private limited company based in Paravada, Andhra Pradesh, India, established in 2014.
2014 Paravada, Andhra Pradesh, India Active
Last Updated:
Access Report
About Averx Drugs Private Limited

Averx Drugs Private Limited, a active private limited company, was established on 26 August 2014 in Paravada, Andhra Pradesh, India. Engaging in animal pharmaceuticals & healthcare within the manufacturing sector, it holds CIN: U24100AP2014PTC095163. Registered under ROC Roc Vijayawada. it is unlisted. It has an authorized capital of ₹10.00 Cr and a paid-up capital of ₹9.91 Cr.

It upholds a compliant status. Its leadership includes Dhana Lakshmi Tirupathi (Director), Nagasekhar Ramineni (Managing Director), Srinivas Ramineni (Additional Director). Past directors included Rama Veera Venkata Siva Prasad Nagireddy, Nagasekhar Ramineni, Uma Rani Burra. It holds ₹7.48 Cr open charges and no settled loans. Its latest AGM occurred on 30 November 2021, with the balance sheet filed on 31 March 2021. It is based at Plot No 27A, 32A And 27A31 Denotified Area, Lalamkoduru, Rambilli, Atchuthapuram, Paravada, Andhra Pradesh, 531019.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24100AP2014PTC095163

  • Registration Number

    095163

  • Incorporation Date

    26 August 2014

  • Authorized Capital

    ₹10.00 Cr

  • Paid-Up Capital

    ₹9.91 Cr

  • ROC Code

    Roc Vijayawada

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 10.00 Cr
  • Paid Up Capital ₹ 9.91 Cr
  • Company Age 11 Year, 7 Months
  • Last Filing with ROC 31 Mar 2021
  • Open Charges ₹ 7.48 Cr
  • Revenue Growth **** 209.54%
  • Profit Growth **** 69.93%
  • Ebitda **** 165.67%
  • Net Worth 67.39%
  • Total Assets **** 14.92%
Company report

Averx Drugs Private Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Averx Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Averx Drugs Private Limited?
Current Directors
Name Designation Appointment Date Status
Dhana Lakshmi Tirupathi Director 25 Apr 2015 Current
Nagasekhar Ramineni Managing Director 27 Mar 2019 Current
Srinivas Ramineni Additional Director 29 Jan 2024 Current
Vns Gopal Raju Kurapati Director 26 Aug 2014 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 09 Apr 2021 Past
Pramod Abcsdd Director 23 May 2024 Past
Pramod Abcsdd Director 11 Jul 2015 Past
Pramod Abcsdd Director 27 Apr 2024 Past
Pramod Abcsdd Managing Director 10 Jul 2015 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Averx Drugs.

Averx Drugs Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 209.54% increase. The company also saw a substantial improvement in profitability, with a 69.93% increase in profit. The company's net worth Soared by an impressive increase of 67.39%.

Averx Drugs revenue growth over time
Averx Drugs profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 209.54%
*******
*******
*******
*******
Revenue from Operations
*******
 231.65%
*******
*******
*******
*******
Total Assets
*******
 14.92%
*******
*******
*******
*******
Profit or Loss
*******
 69.93%
*******
*******
*******
*******
Net Worth
*******
 67.39%
*******
*******
*******
*******
EBITDA
*******
 165.67%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Averx Drugs?

In 2021, Averx Drugs had a promoter holding of 96.01% and a public holding of 3.99%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹74,800,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Others : 7.48 Cr
Latest Charge Details
Date Lender Amount Status
05 Sep 2018 Others ₹2.13 Cr Open
31 Aug 2016 Others ₹5.35 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Averx Drugs?

Unlock and access historical data on people associated with Averx Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Averx Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Averx Drugs's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Averx Drugs
Recent Activity within the Organization
  • Director Appointment

    Srinivas Ramineni was appointed as a Additional Director was appointed as a Additional Director on 29 Jan 2024 & has been associated with this company since 2 years 2 months . was recorded as a recent event.

  • Annual General Meeting

    Averx Drugs Private Limited last Annual general meeting of members was held on 30 Nov 2021 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Progress on Averx Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2021 with Roc Vijayawada. was documented.

  • Director Appointment

    Nagasekhar Ramineni was appointed as a Managing Director was appointed as a Managing Director on 27 Mar 2019 & has been associated with this company since 7 years 6 days . was recorded as a recent event.

  • Charges

    Progress on A charge with Others amounted to Rs. 2.13 Cr with Charge ID 100202612 was registered on 05 Sep 2018. was documented.

  • Charges

    The activity A charge with Others amounted to Rs. 5.35 Cr with Charge ID 100047169 was registered on 31 Aug 2016. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Averx Drugs Private Limited?

The CIN of Averx Drugs Private Limited is U24100AP2014PTC095163.

Where is Averx Drugs Private Limited headquartered?

Averx Drugs Private Limited is headquartered at Plot No 27A, 32A And 27A31 Denotified Area, Lalamkoduru, Rambilli, Atchuthapuram, Paravada, Andhra Pradesh, 531019.

When was Averx Drugs Private Limited incorporated?

Averx Drugs Private Limited was incorporated on 26 August 2014.

Who are the current directors of Averx Drugs Private Limited?

The current directors of Averx Drugs Private Limited are

What is the primary industry of Averx Drugs Private Limited?

The primary industry of Averx Drugs Private Limited is Manufacturing.

Is Averx Drugs Private Limited a listed company?

Averx Drugs Private Limited is unlisted.

What is the capital structure of Averx Drugs Private Limited?

The authorized capital of Averx Drugs Private Limited is ₹10.00 Cr, and the paid-up capital is ₹9.91 Cr.

What is the compliance status of Averx Drugs Private Limited?

The compliance status of Averx Drugs Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available